News | August 09, 2022
Indraprastha Medical Corporation posts Q1 FY23 PAT at Rs. 20.28 Cr
The company has reported total income of Rs. 264.09 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 264.09 crores during the period ended June 30, 2022.
Health resources – both human and material are precious assets to the society and a robust health care administration and management system ensures their effective utilization: Dr Bharati Pravin Pawar
The facility is designed with advanced analytical equipment to provide testing services such as In-vitro Permeation testing
India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21
The GMP facility is equipped with state of art machinery for the needs of Global commercial requirements
The Bill aims to amend and consolidate the law relating to the import, manufacture, distribution and sale of drugs, medical devices and cosmetics
Themis Medicare’s VIRALEX is an effective and safe drug for management of mild to moderate COVID and other acute viral respiratory infections.
Domestic devices are usually preferred over imported medical devices in the national or regional procurement.
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
Cantourage introduces second Clever Leaves medical cannabis product to the German market
Subscribe To Our Newsletter & Stay Updated
